Skip to main content

Table 1 Post-MI day 28 LV parameters

From: Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?

 

LVEF (%)

LVEDV (μl)

LVESV (μl)

SV (μl)

MASS (mg)

Control (n = 17)

27.5 ± 10.5

74.1 ± 26.7

54.8 ± 24.8

19.2 ± 6.4

47.5 ± 13.9

C21 (n = 23)

27.3 ± 11.8

91.6 ± 23.8

66.9 ± 21.5

24.7 ± 13.3

56.7 ± 15.2

p value

0.98

<0.01

<0.05

<0.05

<0.05